{"id":"W2888335003","doi":"10.1200/jco.2007.25.18_suppl.1047","title":"A phase II study of pemetrexed and doxorubicin in patients with advanced or metastatic breast cancer (MBC)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Metastatic breast cancer; Pemetrexed; Doxorubicin; Neutropenia; Breast cancer; Internal medicine; Chemotherapy; Phases of clinical research; Febrile neutropenia; Oncology; Gastroenterology; Surgery; Cancer; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002067586,0.001091389,0.001951488,0.0004448313,0.0003863007,0.0007081534,0.0007593695,0.00113567,0.004394802],"category_scores_gemma":[0.001054654,0.0007003433,0.0008804007,0.0004417398,0.0009041068,0.0006625743,0.0004306294,0.002861771,0.0008441102],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007219572,"about_ca_system_score_gemma":0.001585897,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007490498,"about_ca_topic_score_gemma":0.00127882,"domain_scores_codex":[0.9994209,0.0003519326,0.0000261652,0.00006982712,0.00004277925,0.00008842832],"domain_scores_gemma":[0.9990475,0.0001884542,0.0001212681,0.00006444947,0.00005497902,0.0005233056],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6940107,0.1832985,0.0139966,0.0008691218,0.001265181,0.0004047983,0.0005254811,0.001679451,0.03024705,0.0002535473,0.002969984,0.07047973],"study_design_scores_gemma":[0.5803782,0.4057356,0.009923406,0.00002532971,0.0002533155,0.0002117072,0.00006181948,0.0006988235,0.001030468,0.00007562451,0.001591914,0.00001382927],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938737,0.001204192,0.0003294468,0.0003095141,0.00009282288,0.00293291,0.00031509,0.00002794993,0.000914402],"genre_scores_gemma":[0.9879078,0.001768082,0.001755459,0.0009894685,0.000244732,0.004456062,0.001160624,0.00001692763,0.001700834],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004394802,"threshold_uncertainty_score":0.01470208,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.111861061387562,"score_gpt":0.5453082906213601,"score_spread":0.4334472292337981,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}